What if a psychedelic-inspired compound could treat mood disorders without causing users to hallucinate? Boston-based Onsero is exiting stealth mode, announcing its intent to develop a psychedelic-inspired antidepressant that offer therapeutic benefits without causing a “trip.” Such a drug would avoid the shadow side of classic psychedelics such as LSD and psilocybin. Classic psychedelics continue…